Risque de cancer et infection à VIH

Émilie Lanoy; Marguerite Guiguet

doi:10.1051/medsci/2010264423

Accueil

Tous les numéros

Volume 26 / Numéro 4 (Avril 2010)

Med Sci (Paris), 26 4 (2010) 423-426

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 26, Numéro 4, Avril 2010


Page(s)		423 - 426
Section		Repères
DOI		https://doi.org/10.1051/medsci/2010264423
Publié en ligne		15 avril 2010

Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148 : 728–36. [Google Scholar]
Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52 : 611–22. [Google Scholar]
Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 survey. Clin Infect Dis 2009; 48 : 633–9. [Google Scholar]
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant patient recipients: a meta-analysis. Lancet 2007; 370 : 59–67. [Google Scholar]
Guiguet M, Boué F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective study. Lancet Oncol 2009; 10 : 1152–9. [Google Scholar]
Schulz T. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125 : 1755–63. [Google Scholar]
Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancer among HIV infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23 : 41–50. [Google Scholar]
Silverberg MJ, Abrams DI. Do antiretroviral reduce the risk of non-AIDS defining malignancies. Curr Opin HIV AIDS 2009; 4 : 42–51. [Google Scholar]
HIV-Causal Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV infected individuals. AIDS 2010; 24 : 123–37. [Google Scholar]
Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008; 26 : 4834–42. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148 : 728–36. [Google Scholar]

[2] Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52 : 611–22. [Google Scholar]

[3] Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 survey. Clin Infect Dis 2009; 48 : 633–9. [Google Scholar]

[4] Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant patient recipients: a meta-analysis. Lancet 2007; 370 : 59–67. [Google Scholar]

[5] Guiguet M, Boué F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective study. Lancet Oncol 2009; 10 : 1152–9. [Google Scholar]

[6] Schulz T. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125 : 1755–63. [Google Scholar]

[7] Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancer among HIV infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23 : 41–50. [Google Scholar]

[8] Silverberg MJ, Abrams DI. Do antiretroviral reduce the risk of non-AIDS defining malignancies. Curr Opin HIV AIDS 2009; 4 : 42–51. [Google Scholar]

[9] HIV-Causal Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV infected individuals. AIDS 2010; 24 : 123–37. [Google Scholar]

[10] Spano JP, Costagliola D, Katlama C, et al. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008; 26 : 4834–42. [Google Scholar]